The full list of practices is below
Among the rare ocular side effects of GLP-1RAs is non-arteritic anterior ischemic optic neuropathy (NAION), which can cause permanent loss of vision, states the report, Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice. The report was first presented at the 2025 Optometry's Meeting | 5th World Congress of Optometry and is meant to provide critical guidance to doctors of optometry treating patients on GLP-1RAs
GLP2 once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
People new to GLP-1 agonists If retatrutide is your first exposure to any GLP-1 receptor agonist, start at the lowest practical dose
Book your appointment today Speak to a qualified pharmacist at a time that suits you
[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Mulvihill EE, et al